C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/4196 (2006.01) A61K 31/42 (2006.01) A61P 1/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07D 249/14 (2006.01) C07D 261/14 (2006.01) C07D 405/12 (2006.01) C07D 413/04 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2737639
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Linvention concerne des composés de formule (I), qui se lient au récepteur CB2 dont ils sont des agonistes, des antagonistes ou des agonistes inverses, et sont utiles pour le traitement d'une inflammation. Ceux des composés
Amouzegh Patricia
Bartolozzi Alessandra
Berry Angela
Blumire Nigel James
East Stephen Peter
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Compounds which selectively modulate the cb2 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which selectively modulate the cb2 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which selectively modulate the cb2 receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1869736